Greater London Enterprise Awards 2018

SME NEWS / Greater London Enterprise Awards 2018 5 , EUROIMMUN UK Ltd. is a subsidiary of EUROIMMUN AG, owned by Perkin Elmer Inc. EUROIMMUN and is a worldwide market leader in the provision of immunodiagnostic pathology laboratory solutions, offering an extensive range of reagents and instruments for autoimmune diseases, infectious serology and allergy testing. Showcasing a selection of our winners from the Greater London Enterprise Awards 2018, we profiled EUROIMMUNUK the firm to find out more. Best Medical Diagnostic Products Supplier - UK Established in 2000, EUROIMMUN UK supplies the healthcare industry with medical diagnostic products in the following principal areas: autoimmunity, infectious serology and allergy. Diagnostic test systems are offered alongside fully automated instruments and IT solutions. The organisation’s mission is to provide outstanding diagnostics to healthcare providers in order to assist practitioners to rapidly and accurately diagnose patients to improve and accelerate the recovery pathway in a cost effective and sustainable way. The test systems supplied by EUROIMMUN UK are focussed mainly on indirect immunofluorescence, microplate ELISA, various blot techniques (Western blots, EUROAssay, EUROLINE, EUROLINE-WB) and molecular methods (EUROArray). The company uses worldwide- patented, state-of-the-art production methods and is one of the world’s leading suppliers and manufacturers of medical laboratory diagnostic products. Based in Wimbledon, the firm is proud to offer a complimentary educational facility to support diagnostic laboratories in their work through the International Training Centre. To ensure excellence, EUROIMMUN UK’s clients are at the centre of everything the firm offers, which is epitomised by the firm’s International Training Centre in London. Here, the company offers a complimentary training facility for all of its clients including laboratory and conferencing facilities. Recently, there have been a number of developments in the medical diagnostics market that have affected EUROIMMUN UK. Following publication of the Government-commissioned ‘Lord Carter of Coles report’ in February 2016 various recommendations were made on how to improve efficiency in NHS acute hospitals. Two impacts are Pathology Laboratories consolidating into fewer sites and larger and longer contracts nationwide, which all affect the way the firm operates and strategises. Overcoming these changes, the team at EUROIMMUN UK are all committed to supporting clients and are passionate about the products that they are able to offer. The team at Euroimmun UK view every purchase made by a client, whether small or large, as an investment in them and their team. They view it as a great privilege that clients choose EUROIMMUN UK to purchase from and in return the team aim to offer the best quality products, support, training and trouble-shooting service within their power. Thanks to the incredible success that this approach has produced, moving forward EUROIMMUN UK’s is seeking to expand its offices for the second time in just two years. This will enable the firm to continue to grow in numbers and provide the much- needed space to ensure that it is able to grow at its current rate in the long-term, providing stability for its clients and a wonderful environment for its employees to thrive. As such, there is a bright future ahead for EUROIMMUN UK and its valued clientele. EUROIMMUN UK LON18022 Company: EUROIMMUN UK Contact: Daniel Agustus, PhD Email: [email protected] Address: Ashville House, 131-139 The Broadway, Wimbledon, London, SW19 1QJ, UK Web Address: www.euroimmun.co.uk / www.euroimmun.com